FDA Adverse Event Malfunction Summary report: N

REAGENT RED BLOOD CELLS BIOTESTCELL-P3

MDR report key: 8644017 · Received May 27, 2019

Report

Report Number
9610824-2019-00026
Event Type
Malfunction
Date Received
May 27, 2019
Date of Event
April 29, 2019
Report Date
May 27, 2019
Manufacturer
BIO-RAD MEDICAL DIAGNOSTICS GMBH
Product Code
KSZ
UDI-DI
07611969952397
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
GM
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

THIS IS OUR COMBINED INITIAL AND FINAL REPORT ON THIS INCIDENT.

Description of Event or Problem · 1

THE CUSTOMER REPORTED FALSE NEGATIVE OR WEAKENED REACTIONS OF REAGENT RED BLOOD CELL, CELL 1 = P1 FROM BIOTESTCELL-P3. CELL 1=P1 IS DEFINED IN THE ANTIGEN TABLE AS BEING POSITIVE FOR LUA+B+. THE CUSTOMER DID NOT RETURN THE PRODUCT SAMPLE FOR INVESTIGATIONAL TESTING NOR THE PATIENT SAMPLE THAT HAD CAUSED A FALSE NEGATIVE TEST RESULT. THEREFORE OUR QUALITY CONTROL LABORATORY TESTED THEIR RETENTION SAMPLE OF BIOTESTCELL-P3 (CELL 1), LOT: 2913011-00 WITH BIO-RAD`S ANTI-LUA, LOT # 2910080-00. NEGATIVE CONTROLS, A, LUA+B+ PATIENT SAMPLE AND THREE LUA+B+ RED BLOOD CELLS WERE TESTED FOR ANTIGENICITY. ALL POSITIVE REACTIONS WERE COMPARABLE AND CLEARLY POSITIVE (2+ POS. TO 3+ POS.). WE DID NOT OBSERVE ANY FALSE NEGATIVE REACTION. TESTING BY OUR QUALITY CONTROL LABORATORY CONFIRMED THAT THE ALLEGEDLY DEFECTIVE LOT OF BIOTESTCELL-P3 FUNCTIONS CORRECTLY. A REVIEW OF THE BATCH RECORD DOCUMENTATION SHOWED NO IRREGULARITIES WHICH MIGHT HAVE NEGATIVELY AFFECTED THE QUALITY OF THE ALLEGEDLY DEFECTIVE LOT.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
437715 REAGENT RED BLOOD CELLS BIOTESTCELL-P3 BIOTESTCELL-P3 KSZ BIO-RAD MEDICAL DIAGNOSTICS GMBH 2913011-00 07611969952397

Patients

Seq Age Sex Outcome Treatment
1